2 Drug Stocks Dinged at Goldman



China reportedly halted purchases of soy out of the U.S.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Opening View
 
 

5/30/2019

Turn $1,000 into $1.57 Million – with “Holy Grail of Medicine”

On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can “Cut & Paste” any disease from your body. The Nobel Prize Committee called it “The Holy Grail of Medicine.” This under-the-radar company is not yet a household name.

Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>

unit
Stock Futures Inch Higher After GDP

By Emma Duncan

Share On

U.S. stock futures are inching toward a positive open, with the Dow Jones Industrial Average (DJI) pointed higher, as traders digest the latest gross domestic product (GDP) estimate. The Commerce Department said the U.S. economy grew at a 3.1% pace in the first quarter, exceeding expectations. Bond yields are also on the rise, despite reports that China is halting soy purchases out of the U.S. Futures on the Nasdaq-100 (NDX) and S&P 500 Index (SPX) are also moving higher, though all three indexes remain on pace for a steep monthly loss.

Continue reading for more on today’s market, including: 

  • 2 ETFs with hot options after China’s latest trade threat. 
  • The penny stock that just quadrupled
  • A pair of drug stocks dinged at Goldman.
  • Plus, analysts pounce on Capri; the stock enjoying a Game of Thrones lift; and Dollar Tree sinks on disappointing quarterly report.

>> Continue reading…
LATEST HEADLINES

>> Wall Street Continues Bearish Onslaught of Steel Stocks
X and STLD stocks were hit with more bearish attention
>> Dow Loses 221 Points Amid Trade, Treasury Anxieties
China’s next tariff weapon could be rare earth minerals
>> 3 Stocks Making Volatile Moves Today
Cara Therapeutics stock is higher on its phase 3 results
>> Options Traders Blitz 2 Metals ETFs Amid Trade Tensions
One fund is pacing toward its worst month in years
>> IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
ADVERTISEMENT

A Rare Opportunity to Turn $1,000 into $1.57 Million

On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can “Cut & Paste” any disease from your body. The Nobel Prize Committee called it “The Holy Grail of Medicine.” This under-the-radar company is not yet a household name.

Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>

To ensure delivery of Schaeffer’s Opening View, add us to your contacts! For more information, please visit this link for further instructions.

This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer’s Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don’t want to receive Schaeffer’s Opening View? You can unsubscribe here.

For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions.

Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:

Schaeffer's Opening View


2019-05-30 13:39:08



Source link

Can you get moneyed from fx trading? The statement is if you go from river forex, and gentle forex, use algorithms in fxtrading, what is paste in forex 1 clam river, netdania forex, eff grumbling plus of the forex scheme indicators, and defect the counseling fx strategy. We module win win all.


Top 10 problems you may need in life:

01. Espresso Machines review|
02. Gaming Keyboards review|
03. Gaming Headsets review|
04. Virtual Reality Headsets review|
05. Cordless Drills review|
06. Electric Keyboards review|
07. Gaming Mouse review|
08. Gaming Monitors review|
09. Gaming Laptops review|
10. WiFi Routers review|

You May Also Like

About the Author: Fidelia

A biographical sketch paints an abbreviated picture of someone's life. It can be written about someone else's life or your own life. If you're writing about someone ...

Leave a Reply

Your email address will not be published.